Quest PharmaTech Inc. (TSXV:QPT)
Canada
· Delayed Price · Currency is CAD 0.0350
+0.0050 (16.67%)
At close: Mar 4, 2026
Quest PharmaTech Cash Flow Statement
Financials in millions CAD. Fiscal year is February - January.
Millions CAD. Fiscal year is Feb - Jan.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Oct '25 Oct 31, 2025 | Jan '25 Jan 31, 2025 | Jan '24 Jan 31, 2024 | Jan '23 Jan 31, 2023 | Jan '22 Jan 31, 2022 | Jan '21 Jan 31, 2021 | 2020 - 2016 |
| Net Income | -0.1 | -1.8 | -3.02 | -64.89 | -85.04 | 190.06 | Upgrade
|
| Depreciation & Amortization | - | - | 0 | 0.01 | 0.04 | 0.04 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | - | - | -0.09 | 57.75 | -294.58 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | - | - | 0 | 0 | Upgrade
|
| Loss (Gain) From Sale of Investments | 0.39 | 0.46 | 1.34 | 61.39 | 26.72 | 101.56 | Upgrade
|
| Loss (Gain) on Equity Investments | -0.8 | 0.8 | 0.52 | 3.1 | - | - | Upgrade
|
| Stock-Based Compensation | 0.08 | 0.08 | 0.47 | 0.15 | 0.27 | 0.45 | Upgrade
|
| Other Operating Activities | 0.1 | 0.1 | 0.1 | - | - | -0 | Upgrade
|
| Change in Accounts Receivable | 0.03 | - | 0.02 | -0.22 | 0.03 | -0.02 | Upgrade
|
| Change in Accounts Payable | 0.17 | -0.15 | 0.22 | -0 | 0.02 | -0 | Upgrade
|
| Change in Other Net Operating Assets | 0 | -0 | 0.01 | -0 | 0.03 | -0.03 | Upgrade
|
| Operating Cash Flow | -0.13 | -0.51 | -0.34 | -0.55 | -0.17 | -2.52 | Upgrade
|
| Investment in Securities | - | - | - | - | - | 0.3 | Upgrade
|
| Other Investing Activities | - | - | - | -0.01 | -0.01 | -0.04 | Upgrade
|
| Investing Cash Flow | - | - | - | -0.01 | -0.01 | 0.26 | Upgrade
|
| Short-Term Debt Issued | - | - | 0.2 | 0.5 | 0.25 | 0.25 | Upgrade
|
| Total Debt Issued | - | - | 0.2 | 0.5 | 0.25 | 0.25 | Upgrade
|
| Short-Term Debt Repaid | - | - | -0.2 | - | - | - | Upgrade
|
| Total Debt Repaid | - | - | -0.2 | - | - | - | Upgrade
|
| Net Debt Issued (Repaid) | - | - | - | 0.5 | 0.25 | 0.25 | Upgrade
|
| Issuance of Common Stock | - | - | - | 0.09 | - | 0.05 | Upgrade
|
| Other Financing Activities | - | - | 0.68 | 0.09 | - | - | Upgrade
|
| Financing Cash Flow | - | - | 0.68 | 0.68 | 0.25 | 0.3 | Upgrade
|
| Net Cash Flow | -0.13 | -0.51 | 0.34 | 0.11 | 0.07 | -1.95 | Upgrade
|
| Free Cash Flow | -0.13 | -0.51 | -0.34 | -0.55 | -0.17 | -2.52 | Upgrade
|
| Free Cash Flow Per Share | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.01 | Upgrade
|
| Cash Interest Paid | - | - | - | 0 | 0.01 | 0.01 | Upgrade
|
| Levered Free Cash Flow | -0.12 | -0.5 | -0.02 | -0.59 | -0.11 | -17.96 | Upgrade
|
| Unlevered Free Cash Flow | -0.12 | -0.48 | -0 | -0.58 | -0.1 | -17.95 | Upgrade
|
| Change in Working Capital | 0.2 | -0.16 | 0.25 | -0.23 | 0.08 | -0.05 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.